EXEMPLAR GENETICS, LLC

Biotech · Private

Genetically engineered dystrophic pig models for Duchenne muscular dystrophy research

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026

Sector: Biotech
Total capital: $251K

Federal grants: $151K; 1 award · 2018; Rank in peer group#27 of 28
Private capital raised: None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts: $101K; 3 awards · Defense, Health and Human S; Rank in Biotech#329 of 4373
Granted patents: 3; 10 pending · first 2019; Rank in peer group#2 of 28

Capital timeline

Latest events

Jul 2020Federal contractHealth and Human S · Scd Minipigs -- Catalog # : Scd Minipigs$36K
Apr 2018Federal grantHealth and Human S · Phase II · Development of a Porcine Model of Duchenne Muscular Dystrophy$151K
Sep 2013Federal contractDefense · Female Yucatan Minipigs$65K
Sep 2009Federal contractDefense · Mini Swine$50

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 28 peers

Line = median

Biotech · Instrument

Federal grantsBelow median
Granted patents#2 · top 7%
Linked publications#2 · top 7%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 3 granted of 13

Feb 25, 2020GrantedAnimal Models of AtherosclerosisUSPTOUS 10,568,974
Sep 5, 2019PendingAnimal Models Of CancerUSPTOApplication 16183858
Jan 22, 2019GrantedAnimal Models Of Duchenne Muscular DystrophyUSPTOUS 10,183,978

Show all 13 patent records

Animal Models of AtherosclerosisFeb 25, 2020 · US 10,568,974Granted
Animal Models Of CancerSep 5, 2019 · Application 16183858Pending
Animal Models Of Duchenne Muscular DystrophyJan 22, 2019 · US 10,183,978Granted
Animal Models of CancerJan 8, 2019 · US 10,172,333Granted
Animal Models of Ataxia-Telangiectasia (A-T)May 26, 2016 · Application 14776677Pending
Animal Models of CancerApplication 61951896Pending
Animal Models Of CancerApplication PCTUS2014029532Pending
Animal Models Of Duchenne Muscular DystrophyApplication PCTUS2014013083Pending
Animal Models of Ataxia-Telangiectasis (A-T)Application 61788080Pending
Animal Models of CancerApplication 61788518Pending
Animal Models Of AtherosclerosisApplication PCTUS2013000031Pending
Animal Models of Duchenne Muscular DystrophyApplication 61757203Pending
Animal Models Of Ataxia-telangiectasis (a-t)Application PCTUS2014029248Pending

Recent research by its founders

Abstract 4367417: A-band titin-truncating variant promotes the development of arrhythmia-induced cardiomyopathy in a novel genetically-engineered porcine model20250 cites
<i>NF1<sup>+/ex42del</sup></i> miniswine model the cellular disruptions and behavioral presentations of <scp>NF1</scp>‐associated cognitive and motor impairment20243 cites
Regenerative Therapy of Hip and Related Joints, Ligaments, and Tendons20240 cites

Xona Microfluidics, Inc.Similar federal contract value in Biotech · $104K in contracts
IMANIS LIFE SCIENCES, LLCSimilar federal contract value in Biotech · $101K in contracts
CARRYGENES BIOENGINEERING, LLCSimilar federal contract value in Biotech · $101K in contracts
SYNZYME TECHNOLOGIES LLCSimilar federal contract value in Biotech · $100K in contracts
B-MoGen Biotechnologies IncSimilar federal contract value in Biotech · $100K in contracts
ADVAITA CORPSimilar federal contract value in Biotech · $97K in contracts

Regulatory activity · Biotech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.